Welcome to LookChem.com Sign In|Join Free
  • or
2-Pyridinecarboxamide, 4-(4-aminophenoxy)-N-(1-methylethyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

284462-89-1

Post Buying Request

284462-89-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

284462-89-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 284462-89-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,4,4,6 and 2 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 284462-89:
(8*2)+(7*8)+(6*4)+(5*4)+(4*6)+(3*2)+(2*8)+(1*9)=171
171 % 10 = 1
So 284462-89-1 is a valid CAS Registry Number.

284462-89-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(2-(N-isopropylcarbamoyl)-pyridin-4-yloxy)aniline

1.2 Other means of identification

Product number -
Other names 4-(2-(N-isopropylcarbamoyl)-4-pyridyloxy)aniline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:284462-89-1 SDS

284462-89-1Relevant academic research and scientific papers

Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

-

, (2008/06/13)

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

OMEGA-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS

-

Page/Page column 24, (2010/01/31)

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 284462-89-1